PGD3 Formation: Metabolized from EPA via COX Pathway
Equipotent to PGD2: Reduces Systemic Blood Pressure in Rats and Intraocular Pressure in Rabbits
Potency: 3-5 Times Greater than PGD2 in Inhibiting ADP-Induced Human Platelet Aggregation
وصف
PGD3, derived from EPA through the COX pathway, matches PGD2's ability to lower systemic blood pressure in rats and intraocular pressure in rabbits. Notably, it's 3-5 times stronger than PGD2 in inhibiting ADP-induced human platelet aggregation.